This inventor holds 1 USPTO granted patent. Top assignee: Riken Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Muneaki Hashimoto: Innovator in Therapeutic Agents
Introduction
Muneaki Hashimoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of diseases associated with parasites. His innovative approach utilizes mechanisms that differ from conventional technologies.
Latest Patents
Muneaki Hashimoto holds a patent for a therapeutic agent designed to treat a-associated diseases. This agent employs an antisense oligonucleotide that suppresses the expression of an inositol 1,4,5-trisphosphate receptor protein in parasites. The method not only aims to prevent infections caused by parasites but also focuses on effectively killing them.
Career Highlights
Hashimoto is affiliated with Riken Corporation, a leading research institution in Japan. His work has been instrumental in advancing therapeutic strategies that address parasitic infections. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Muneaki Hashimoto has collaborated with notable colleagues, including Takeshi Nara and Katsuhiko Mikoshiba. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in therapeutic research.
Conclusion
Muneaki Hashimoto's contributions to the field of therapeutic agents highlight his commitment to advancing medical science. His innovative approaches and collaborations continue to pave the way for new treatments against parasitic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile